Product Information

CLOBAZAM 2.5 MG/ML SUSPENSION is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1765 per ML under NDC 59651040112. Its NADAC has been published 181 times since Jun 7, 2023.

FDA first approved this application on Mar 24, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CLOBAZAM 2.5 MG/ML SUSPENSION

Clobazam
$0.1765per ML
DEA Schedule CIV

Strength

2.5 mg/mL

NDC

59651040112

Classification

Generic

Dosage Form

SUSPENSION

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

CLOBAZAM

Approval Type

Generic (ANDA)

FDA Application

ANDA214404

FDA Approved

3/24/2022

TE Code

AB

On Market Since

3/24/2022

Pharmacological Classes

Benzodiazepine
Benzodiazepines
Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A4 Inducers

Price Statistics

The NADAC for CLOBAZAM 2.5 MG/ML SUSPENSION has been published 181 times since Jun 7, 2023, and over the history we have for it it has declined 41.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1765 per ML
All-time high$0.3316 (Aug 16, 2023)
All-time low$0.1530 (May 20, 2026)
52-week high$0.1909
52-week low$0.1530
Median price$0.1926
Average price$0.2065
Largest weekly change+32.4% (Aug 21, 2024)
Weeks tracked181
Tracking sinceJun 7, 2023

Price History

1W

-3.1%

1M

+2.0%

3M

+4.6%

6M

+15.4%

1Y

-7.5%

3Y

-33.4%

5Y

N/A

All

-41.5%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CLOBAZAM 2.5 MG/ML SUSPENSION?

The current National Average Drug Acquisition Cost (NADAC) for CLOBAZAM 2.5 MG/ML SUSPENSION, manufactured by Aurobindo Pharma Limited, is $0.1765 per ML (NDC 59651040112), effective Nov 18, 2026.

How has the price of CLOBAZAM 2.5 MG/ML SUSPENSION changed over time?

Over the history we have for it, the NADAC for CLOBAZAM 2.5 MG/ML SUSPENSION has declined 41.5%. It has been tracked across 181 weekly CMS publications since Jun 7, 2023.

What are the highest and lowest recorded NADAC prices for CLOBAZAM 2.5 MG/ML SUSPENSION?

Since Jun 7, 2023, the NADAC for CLOBAZAM 2.5 MG/ML SUSPENSION has ranged from a low of $0.1530 (May 20, 2026) to a high of $0.3316 (Aug 16, 2023), with a median of $0.1926 per ML.

Are there cheaper alternatives to CLOBAZAM 2.5 MG/ML SUSPENSION?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLOBAZAM 2.5 MG/ML SUSPENSION in a comparable dosage form, but none are currently priced below it.

Who manufactures CLOBAZAM 2.5 MG/ML SUSPENSION?

CLOBAZAM 2.5 MG/ML SUSPENSION (NDC 59651040112) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.